Ana Maria Abreu-Velez Selected Research

Ana Maria Abreu-Velez Research Topics

Disease

8	Pemphigus and fogo selvagem 07/2022 - 10/2009
4	DiGeorge Syndrome (Syndrome, DiGeorge) 10/2022 - 06/2011
4	Pemphigus (Pemphigus Vulgaris) 10/2022 - 12/2011
3	Blister (Bulla) 09/2015 - 11/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2012 - 09/2010
2	Bullous Pemphigoid (Pemphigoid) 01/2012 - 11/2010
2	Alopecia (Baldness) 06/2011 - 09/2009
2	Infections 09/2010 - 01/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2019
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 09/2015
1	Skin Diseases (Skin Disease) 09/2015
1	Melanoma (Melanoma, Malignant) 10/2012
1	Neoplasms (Cancer) 10/2012
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2012
1	Rheumatoid Arthritis 01/2012
1	Hereditary Nephritis (Alport Syndrome) 01/2012
1	Pathologic Processes 01/2012
1	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 01/2012
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2012
1	Myocarditis (Carditis) 12/2011
1	Diabetes Mellitus 06/2011
1	Discoid Lupus Erythematosus 05/2011
1	Seborrheic Keratosis 03/2011
1	Erythema 02/2011
1	Drug Eruptions (Drug Eruption) 02/2011
1	Virus Diseases (Viral Diseases) 09/2010
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 09/2010
1	Atopic Dermatitis (Atopic Eczema) 07/2010
1	Atrophy 06/2010
1	Lichen Planus (Lichen Ruber Planus) 06/2010
1	Scabies (Sarcoptic Mange) 01/2010
1	Pruritus (Itching) 01/2010
1	Exanthema (Rash) 01/2010
1	Vasculitis (Vasculitides) 11/2009
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 09/2009

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 07/2022 - 10/2009
8	AntibodiesIBA 10/2022 - 01/2010
6	AntigensIBA 10/2022 - 09/2009
5	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2011
3	Desmoplakins (Desmoplakin)IBA 10/2022 - 06/2011
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2012 - 01/2010
3	Hematoxylin (Haematoxylon)IBA 10/2012 - 01/2010
2	Conjugated (USP) Estrogens (Premarin)FDA Link 10/2022 - 01/2018
2	CollagenIBA 01/2012 - 02/2011
2	Peroxidase (Myeloperoxidase)IBA 02/2011 - 11/2009
2	Immunoglobulin E (IgE)IBA 11/2010 - 06/2010
2	Junctional Adhesion MoleculesIBA 09/2010 - 01/2010
1	Antinuclear AntibodiesIBA 10/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 12/2019
1	DesmogleinsIBA 10/2018
1	Armadillo Domain ProteinsIBA 10/2017
1	CateninsIBA 10/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 09/2015
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2015
1	isothiocyanic acidIBA 09/2015
1	MART-1 AntigenIBA 10/2012
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2012
1	KalininIBA 01/2012
1	Collagen Type IV (Type IV Collagen)IBA 01/2012
1	AutoantigensIBA 12/2011
1	EpitopesIBA 12/2011
1	PlakinsIBA 12/2011
1	Fibrinogen (Factor I)FDA Link 06/2011
1	Complement C3 (C3 Complement)IBA 06/2011
1	SurvivinIBA 06/2011
1	Insulin (Novolin)FDA Link 06/2011
1	Protein Kinases (Protein Kinase)IBA 05/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2011
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2011
1	Coloring Agents (Dyes)IBA 02/2011
1	Sulfamethoxazole FDA LinkGeneric 02/2011
1	Trimethoprim (Proloprim)FDA LinkGeneric 02/2011
1	Complement System Proteins (Complement)IBA 11/2010
1	Immunoglobulins (Immunoglobulin)IBA 11/2010
1	Immunoglobulin G (IgG)IBA 11/2010
1	Methotrexate (Mexate)FDA LinkGeneric 09/2010
1	Prednisone (Sone)FDA LinkGeneric 09/2010
1	Keratins (Keratin)IBA 07/2010
1	Filaggrin ProteinsIBA 07/2010
1	ezrinIBA 01/2010
1	A 19IBA 01/2010
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2009
1	Pattern Recognition ReceptorsIBA 09/2009